SCHEMBL29566573

SCHEMBL29566573

CNC(=O)c1ccc(Oc2nc(NS(=O)(=O)c3cnn(C)c3)nc(-c3ccccc3C)c2C)cn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 3/20 0.34
▸ HTR7 P34969 3/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ FGFR1 P11362 3/20 0.34
▸ FGFR3 P22607 1/20 0.34
▸ AURKA O14965 1/20 0.33
▸ AURKB Q96GD4 1/20 0.33
▸ PDE10A Q9Y233 1/20 0.33
▸ EGFR P00533 2/20 0.33
▸ KDR P35968 2/20 0.33
▸ MCL1 Q07820 1/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ PCK1 P35558 1/20 0.32
▸ CCNC P24863 1/20 0.32
▸ CDK8 P49336 1/20 0.32
▸ BTK Q06187 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309774 1.00 HTR1A (0.34) HTR1AHTR7HRH3FGFR1FGFR3
SCHEMBL26808701 0.92 PDE10A (0.36) HTR1AHTR7HRH3FGFR1FGFR3
SCHEMBL26811495 0.92 PARP1 (0.34) HTR1AHTR7HRH3FGFR1FGFR3
SCHEMBL29567325 0.90 FGFR1 (0.39) HTR1AHTR7FGFR1FGFR3AURKA
SCHEMBL24309822 0.90 FGFR1 (0.39) HTR1AHTR7FGFR1FGFR3AURKA
SCHEMBL29566810 0.86 FGFR1 (0.40) HTR1AHTR7FGFR1FGFR3EGFR
SCHEMBL24309919 0.86 FGFR1 (0.40) HTR1AHTR7FGFR1FGFR3EGFR
SCHEMBL24309861 0.85 HTR1A (0.40) HTR1AHTR7FGFR1AURKAAURKB
SCHEMBL29567228 0.85 HTR1A (0.40) HTR1AHTR7FGFR1AURKAAURKB
SCHEMBL24309827 0.82 HTR1A (0.43) HTR1AHTR7FGFR1EGFRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback